IntelliCyt manufactures and sells integrated instrumentation, software, and reagent solutions that facilitate the study of cells to gain a better understanding of normal and disease processes.
IntelliCyt, a leading provider of integrated platforms that accelerate drug discovery, antibody screening and immuno-oncology research, announced today it has been acquired by Sartorius, a leading international pharmaceutical and laboratory equipment provider. IntelliCyt, based in Albuquerque, New Mexico, has developed and commercialized an award-winning, novel cell screening platform that assesses multiple cellular parameters with unmatched speed, efficiency and ease of use.
By coupling the global market presence and strong infrastructure of Sartorius with IntelliCyt’s enabling cell analysis platform, we will be better able to deliver value to our customers, further penetrate our core markets, and grow the business to the next level.
- Terry Dunlay / Founder & CEO, IntelliCyt